Read a COA step by step
Understand identity, purity, analytical methods and lot matching.
COA reading guide →Learn
NEXTWAVE PEPTIDES / LEARN
Peptide research foundations, explained.
Learn is the NEXTWAVE PEPTIDES reference library for compound identity, receptor terminology and analytical documentation. Start with a foundation guide, then follow related articles to examine a specific research question.
Map the core receptor families
Orient yourself to GLP-1 and multi-receptor research before comparing experiments.
GLP-1 and multi-receptor overview →Understand the KLOW components
Distinguish the four components and the limits of ingredient-level evidence.
KLOW Blend components →
Is Semaglutide FDA Approved? Product Form, Brand, and Indication MatterFDA approval applies to specific semaglutide products such as Ozempic, Rybelsus, and Wegovy, not every material bearing the ingredient name.- KLOW Blend Stability: Can One Storage Claim Apply to Four Peptides?A KLOW storage claim requires blend-specific stability data. Map the formulation, container, time, conditions, assays, and acceptance criteria needed.
- How Long Does Semaglutide Last? Half-Life, Circulation, and Effect DurationSemaglutide labels report an approximately one-week half-life. Learn why circulation, assay detection, and effect duration are different questions.
- Tirzepatide vs Mounjaro: Active Molecule, Brand Name, and Product RecordMounjaro contains tirzepatide, but a molecule name and an FDA-approved product record are not interchangeable. Compare the exact identity boundaries.
- Does Semaglutide Need Refrigeration? Why Product Form Changes the AnswerCompare current storage records for semaglutide injections, tablets, and lyophilized research material without transferring one product's instructions to another.
- What Color Is Tirzepatide? Why Appearance Cannot Confirm IdentityFDA labeling describes a specific tirzepatide solution as clear and colorless to slightly yellow. Learn why appearance cannot confirm peptide identity.
- Semax Half-Life: What Stability Studies Can and Cannot Tell UsA validated human Semax half-life is not established in the cited literature. Learn what enzyme and biological-media stability studies actually show.
- Cagrilintide Half-Life: What Human Pharmacokinetic Studies ReportA Phase 1b study reported a 159-195 hour cagrilintide half-life. Learn what the range measures and why it is not a batch specification.
- Semaglutide Ingredients: Active Peptide, Excipients, and Product FormLearn why semaglutide is the active peptide while injection, tablet, compounded, and research-material ingredient records require separate sources.
- Retatrutide Chemical Structure: Formula, Sequence, and LipidationLearn how retatrutide’s 39-residue backbone, noncanonical amino acids, Lys17 lipidation, and receptor assays define separate evidence layers.
- Peptide Freeze–Thaw Stability: Why Cycle Count, Container, and Matrix Must Be ReportedLearn why peptide freeze-thaw stability records must define cycle count, temperatures, matrix, concentration, container, handling, and endpoint.
- Peptide Aggregation Analysis: Why SEC, DLS, and RP-HPLC Answer Different QuestionsCompare SEC, DLS, and RP-HPLC for peptide aggregation analysis, including what each method measures and the blind spots that cause disagreement.
Use the Blog to explore individual studies and comparison questions. Browse peptide collections for related materials, or consult the COA Library for available product- and lot-specific documentation.
RESEARCH SUPPORT
Continue to a primary NextWave destination
Articles provide context and reinforce the main research pillar, calculator and analytical trust center.